Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 228 of 1,261
  1. US 11491125

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    AMNEAL PHARMACEUTICALS LLC · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  2. US 11491187

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  3. US 11491145

    Combination therapies comprising targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  4. US 11491115

    Nanoparticles containing extracellular matrix for drug delivery

    The Board of Regents of the University of Texas System · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  5. US 11491111

    Thermostable vaccine compositions and methods of preparing same

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  6. US 11492604

    Transposase polypeptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  7. US 11492388

    Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  8. US 11491215

    Antigenic combinations against Francisella bacteria and related nanolipoprotein particles, compositions, methods and systems

    The Regents of the University of New Mexico · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  9. US 11491231

    Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials

    Northwestern University · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  10. US 11491238

    Exon skipping oligomer conjugates for muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  11. US 11492643

    Methods and compositions for treatment of a genetic condition

    Sangamo Therapeutics, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  12. US 11491123

    Pharmaceutical compositions with antiflaviviral activity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  13. US 11490643

    Lactobacillus casei for treating obesity and associated metabolic disorders

    PrecisionBiotics Group Limited · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  14. US 11491193

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  15. IT 202100010802

    FORMULAZIONE SOLIDA MUCOADESIVA COMPRENDENTE PROBIOTICI PER USO NELLA PREVENZIONE E NEL TRATTAMENTO DI DISBIOSI ORALE.

    ALFASIGMA SPA [IT] · Granted Nov 3, 2022 · Expires Oct 29, 2042

    granted
  16. US 2022348923

    CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

    BRACCO IMAGING SPA [IT] · Granted Nov 3, 2022 · Expires Oct 29, 2042

    granted
  17. WO 2022229817

    VACCINS COMPRENANT DES PARTICULES PSEUDO-VIRALES PRÉSENTANT DES ANTIGÈNES DU SARS-COV-2 ET LEURS MÉTHODES D'UTILISATION

    BAVARIAN NORDIC AS [DK] · Granted Nov 3, 2022 · Expires Oct 29, 2042

    granted
  18. US 11484573

    Activin receptor type IIa variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  19. US 11484602

    Bicyclic peptide ligands specific for EphA2

    BicycleTx Limited · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  20. US 11484477

    Dental adhesive material kit

    KURARAY NORITAKE DENTAL INC. · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  21. US 11485958

    HSD17B13 variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  22. US 11484523

    Compositions for prevention and treatment of symptoms associated with alcohol consumption

    Purple Biosciences LLC · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  23. US 11484521

    Antidotes to cyanide poisoning

    The Regents of the University of California · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  24. US 11484511

    Pharmaceutical composition comprising THA as effective ingredient for treatment of prostate cancer

    KOREA UNITED PHARM. INC. · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.